Download Product Catalogue

Product Detail

KALSTIN-3

Kalstin-3

Colistimethate 3 MIU Injection

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections.

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

MRP: ₹3450/-
Send Enquiry

100%

Certified Products

Secure

pAYMENTS

24/7

Customer Support

100%

Certified Products

Secure

PAYMENTS

24/7

Customer Support

About The Product

Uses

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

Side Effects

  • Nephrotoxicity (kidney related issues) Neurotoxicity (dizziness, confusion, tingling feeling) Dyspnea (uncommon) Allergies - rash, itching, swelling Pain or irritation at the injection site

Uses

Therapy of severe multidrug-resistant (MDR) Gram-negative bacterial infections. Active against Pseudomonas aeruginosa infections, Acinetobacter baumannii infections, Klebsiella pneumoniae infections. Applied in septicemia, pneumonia, urinary tract infection, intra-abdominal infection, and meningitis (in case of failure of other antibiotics).

Side Effects

  • Nephrotoxicity (kidney related issues) Neurotoxicity (dizziness, confusion, tingling feeling) Dyspnea (uncommon) Allergies - rash, itching, swelling Pain or irritation at the injection site

Indications

  • Nephrotoxicity (Kidney damage - increase in creatinine, decreased urine output) Neurotoxicity (Dizziness, tingling, weakness of muscles, confusion, seizures) Difficulty with breathing in certain instances It should be dosed differently in patients with renal issues.

FAQ

Q1. What is Colistimethate 3 MIU?
It is applied to the treatment of severe multidrug-resistant Gram-negative bacterial infections, particularly in severely ill patients.

Q2. Are patients with kidney disease safe?
Precaution is necessary. In renal impairment, dose reduction is required to avoid toxicity.

Q3. Is it possible to take Colistimethate along with other antibiotics?
Yes, it is usually used in combination with other antibiotics (such as carbapenems, tigecycline or aminoglycosides) to act synergistically against MDR infections.

Q4. What is its administration?
After reconstitution, it is administered intravenously (IV infusion), typically in a hospital.

Q5. Is there any monitoring requirement?
Yes. During the treatment, kidney functioning tests and neurological status should be monitored on a regular basis.

Indications

  • Nephrotoxicity (Kidney damage - increase in creatinine, decreased urine output) Neurotoxicity (Dizziness, tingling, weakness of muscles, confusion, seizures) Difficulty with breathing in certain instances It should be dosed differently in patients with renal issues.

FAQ

Q1. What is Colistimethate 3 MIU?
It is applied to the treatment of severe multidrug-resistant Gram-negative bacterial infections, particularly in severely ill patients.

Q2. Are patients with kidney disease safe?
Precaution is necessary. In renal impairment, dose reduction is required to avoid toxicity.

Q3. Is it possible to take Colistimethate along with other antibiotics?
Yes, it is usually used in combination with other antibiotics (such as carbapenems, tigecycline or aminoglycosides) to act synergistically against MDR infections.

Q4. What is its administration?
After reconstitution, it is administered intravenously (IV infusion), typically in a hospital.

Q5. Is there any monitoring requirement?
Yes. During the treatment, kidney functioning tests and neurological status should be monitored on a regular basis.

Request a Callback